Valproic acid
VPA
effective
treatment
epilepsy
associated with
increase
body weight
nonalcoholic fatty liver disease
NAFLD
child
obesity
VPA
treatment
Laboratory data
hyperinsulinemia
insulin resistance
withdrawal
VPA
therapy
patient
significant weight loss
decrease
body mass index
normalization
metabolic
endocrine
parameters
ultrasound
measurements
complete
normalization
obesity
hyperinsulinemia
insulin resistance
long-term
treatment
VPA
associated with
development
NAFLD
side effect
reversible
VPA
withdrawal
